The content on this site is intended for healthcare professionals only
Dr Stefan Zimmerman speaks with ecancertv at ESMO 2016 to summarise newly reported advances in lung cancer.
He comments on the press conference presentations of Dr Giorgio Scagliotti, Dr Martin Reck, Dr Fabrice Barlesi and Dr Corey Langer who spoke about different immunologic and cell cycle therapies improving progression free survival and overall survival of patients.
ecancer's filming at ESMO 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
ASCO GU 2026: Updates in bladder cancer
Tepotinib in second line NSCLC treatment
Key insights from lung cancer research at ASCO 2025
ELCC 2025: Latest in EGFR positive NSCLC
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ASCO 2024: Lung cancer highlights
